| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/14/2013 | CN102370681B Application of extracts of Chinese herbal medicine rhizoma ligustici wallichii in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity |
| 08/14/2013 | CN102370676B Application of extracts of Chinese herbal medicine fructus chebulae in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity |
| 08/14/2013 | CN102274271B Soybean plantworms mycelium powder and preparation method thereof |
| 08/14/2013 | CN101926853B Medicine composition with function of lowering blood sugar level as well as preparation method and application thereof |
| 08/14/2013 | CN101909604B Method of treating dysglycemia and glucose excursions |
| 08/14/2013 | CN101883772B Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| 08/14/2013 | CN101664551B Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/14/2013 | CN101601760B Application of murraya jasminorage leaf total flavonoids in preparing medicaments for treating diabetes |
| 08/14/2013 | CN101486682B N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/14/2013 | CN101461523B Health-care food oral liquid assistant for reducing blood fat and technique for preparing the same |
| 08/14/2013 | CN101106986B Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 08/13/2013 | US8507748 Method for the production of a single heavy chain antibody |
| 08/13/2013 | US8507557 Potentiators of insulin secretion |
| 08/13/2013 | US8507480 Isoxazole compounds as inhibitors of heat shock proteins |
| 08/13/2013 | US8507475 Substituted heteroarylamide diazepinopyrimidone derivatives |
| 08/13/2013 | US8507473 3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders |
| 08/13/2013 | US8507466 Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy |
| 08/13/2013 | US8507461 Non-absorbable non-digestible polymer compounds |
| 08/13/2013 | US8507428 Glucagon analogs exhibiting GIP receptor activity |
| 08/13/2013 | US8506987 Ocular implant made by a double extrusion process |
| 08/13/2013 | CA2768841C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768828C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768773C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2670892C Substituted diazepan compounds as orexin receptor antagonists |
| 08/13/2013 | CA2649822C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 08/13/2013 | CA2629348C Glucagon receptor antagonists, preparation and therapeutic uses |
| 08/13/2013 | CA2625967C Compositions and methods for increasing lean muscle mass and/or reducing fat gain |
| 08/13/2013 | CA2619566C 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 08/13/2013 | CA2619448C 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 08/13/2013 | CA2613365C Phenoxy acetic acids as ppar delta activators |
| 08/13/2013 | CA2580409C Triazole derivative or salt thereof |
| 08/13/2013 | CA2570041C Process for the preparation of nateglinide |
| 08/13/2013 | CA2521229C Improved dietary fiber containing materials comprising low molecular weight glucan |
| 08/13/2013 | CA2410224C Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 08/08/2013 | WO2013116721A1 Retinaldehyde mimetics and inhibitors of retinaldehyde dehydrogenase i in the treatment of disorders |
| 08/08/2013 | WO2013116138A1 Anti-inflammatory and antioxidant composition and related method of use |
| 08/08/2013 | WO2013116075A1 Benzyl sulfonamide derivatives useful as mogat - 2 inhibitors |
| 08/08/2013 | WO2013116065A1 Novel morpholinyl derivatives useful as mogat-2 inhibitors |
| 08/08/2013 | WO2013116062A1 Salt replacement compositions and methods of using same |
| 08/08/2013 | WO2013115740A1 Synergisctic combination comprising a meglitinide derivative and lipoic acid |
| 08/08/2013 | WO2013115739A1 Production method for formulations comprising comprising nateglinide and lipoic acid |
| 08/08/2013 | WO2013115486A1 Novel piperine derivative and use therefor |
| 08/08/2013 | WO2013114403A1 Substituted 4,5-dihydro-2h-benzo[e]indazole-9-carboxylates for the treatment of diabetes and related disorders |
| 08/08/2013 | WO2013114390A1 Gastro retentive drug delivery system of calcium supplements |
| 08/08/2013 | WO2013085338A3 Pharmaceutical composition for preventing and treating metabolic diseases, comprising nymphaea tetragona root extract, fractions thereof, or polyphenol-based compounds isolated from the nymphaea tetragona root extract as active ingredients |
| 08/08/2013 | US20130203977 Oligonucleotides comprising alternating segments and uses thereof |
| 08/08/2013 | US20130203870 Animal Models of Atherosclerosis |
| 08/08/2013 | US20130203805 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 08/08/2013 | US20130202722 Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof |
| 08/08/2013 | US20130199922 Controlling Chemical Reactions by Spectral Chemistry and Spectral Conditioning |
| 08/07/2013 | EP2623599A1 Micromirs |
| 08/07/2013 | EP2623504A1 5,6-Disubstituted oxindole derivatives and their use in the manufacture of a medicament for the treatment of vasopressin-dependent diseases |
| 08/07/2013 | EP2623120A2 Compositions comprising dietary fat complexer and methods for their use |
| 08/07/2013 | EP2623109A1 Enteral nutrient |
| 08/07/2013 | EP2621891A1 Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same |
| 08/07/2013 | EP2621519A2 Engineered polypeptides having enhanced duration of action |
| 08/07/2013 | EP2621515A2 Highly soluble leptins |
| 08/07/2013 | EP2621509A2 Formulations of guanylate cyclase c agonists and methods of use |
| 08/07/2013 | EP2621493A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS |
| 08/07/2013 | EP2621282A2 Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes |
| 08/07/2013 | CN103237803A Triazolopyridine compounds |
| 08/07/2013 | CN103232538A Sulfhydrylation modified collagen calcium compound |
| 08/07/2013 | CN103232521A Tanshinone imidazole compound and its preparation method and use |
| 08/07/2013 | CN103232520A Spirosteroid compounds and preparation method and medical application thereof |
| 08/07/2013 | CN103232486A Vanadium oxide complex as well as preparation method and application thereof |
| 08/07/2013 | CN103232474A Histone deacetylase inhibitors |
| 08/07/2013 | CN103232398A Rosuvastatin amino acid salt as well as preparation method and application thereof |
| 08/07/2013 | CN103232350A Acylated Danshensu derivative and application thereof to preventing and treating cerebrovascular and liver and kidney diseases |
| 08/07/2013 | CN103232348A Fibrate-natural antioxidant twin drug used for treating hyperlipidemia, and preparation method thereof |
| 08/07/2013 | CN103230594A Medicine composition of alpha-glucosidase inhibitor and vitamin B |
| 08/07/2013 | CN103230592A Composition of statin medicine and 5-methyltetrahydrofolic acid, and application thereof |
| 08/07/2013 | CN103230552A Traditional Chinese medicine for treating diabetes mellitus |
| 08/07/2013 | CN103230538A Fresh dendrobium officinale American ginseng particle and preparation method thereof |
| 08/07/2013 | CN103230507A Genic health-care granule for keeping in-vivo alkalescence and preparation method of granule |
| 08/07/2013 | CN103230497A Health product with function of reducing blood sugar and preparation method thereof |
| 08/07/2013 | CN103230482A Extract for reducing blood pressure and adjusting blood fat and its preparation method and use |
| 08/07/2013 | CN103230474A Rose-pine needle distillate oral liquid and preparation method thereof |
| 08/07/2013 | CN103230473A Lycium ruthenicum Murr effective extract and its extraction method and use |
| 08/07/2013 | CN103230472A Comprehensive treatment Chinese patent medicine of internal and external application for treating diabetes mellitus |
| 08/07/2013 | CN103230444A Traditional Chinese medicine composition for lowering lipid and protecting liver as well as preparation method and application thereof |
| 08/07/2013 | CN103230426A Medical composition for treating diabetes mellitus and complications thereof |
| 08/07/2013 | CN103230425A Method for extracting high-content malonyl ginsenoside from fresh ginseng by membrane separation method |
| 08/07/2013 | CN103230422A A curcumin healthy granule and a preparation method thereof |
| 08/07/2013 | CN103230411A Application of fucoidan polysaccharide sulfate in preparing drug for preventing and/or treating diabetic cardiomyopathy |
| 08/07/2013 | CN103230408A Method for preparing phloretin |
| 08/07/2013 | CN103230402A Drug composition containing various lipid-soluble vitamins and preparation thereof |
| 08/07/2013 | CN103230395A Preparation method of compound amino acid injection (15-HBC) |
| 08/07/2013 | CN103230387A Entero-soluble type compound acidifier pellet and preparation method thereof |
| 08/07/2013 | CN103230376A Simvastatin tablet preparation method |
| 08/07/2013 | CN103230368A Statin medicine preparation method |
| 08/07/2013 | CN103230358A Use of quinoa extract as cosmetic and pharmaceutic slimming agent and/or as an agent preventing the formation of new fats in the human body |
| 08/07/2013 | CN103230019A Emulsified olive oil and preparation method thereof |
| 08/07/2013 | CN103230008A Health care food with weight losing function and preparation method of food |
| 08/07/2013 | CN103230002A DHA (docosahexaenoic acid) liposome preparation method |
| 08/07/2013 | CN102875513B Microcrystal catechin and preparation method thereof |
| 08/07/2013 | CN102603886B Mutant fibroblast growth factor and use thereof in treating endocrine diseases |
| 08/07/2013 | CN102580024B Composition for treating cardiovascular diseases |
| 08/07/2013 | CN102579801B Traditional Chinese medicine preparation for treating diabetic syndrome and preparation method of same |
| 08/07/2013 | CN102579798B Oral traditional Chinese medicine composition for curing diabetes |
| 08/07/2013 | CN102552168B Pharmaceutical composition containing orlistat and its preparation method |